MeSH term
Frequency | Condition_Probility | Chromosomes, Human, Pair 3 | 2 | 1.0 |
DNA Mutational Analysis | 10 | 0.0 |
DNA-Binding Proteins/*genetics | 16 | 0.0 |
Humans | 54 | 0.0 |
*Mutation | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 44 | 0.0 |
Transcription Factors/*genetics | 14 | 0.0 |
Animals | 16 | 0.0 |
Binding Sites | 3 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics | 7 | 5.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
*Gene Expression Regulation | 4 | 0.0 |
Hela Cells | 3 | 0.0 |
Myelin Proteins/genetics | 7 | 12.0 |
Point Mutation | 2 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Male | 20 | 0.0 |
Adult | 10 | 0.0 |
Base Sequence | 15 | 0.0 |
Comparative Study | 7 | 0.0 |
Connexins/genetics | 5 | 11.0 |
DNA Mutational Analysis/*methods | 3 | 2.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Female | 16 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
Pedigree | 5 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Expressed Sequence Tags | 2 | 0.0 |
Molecular Sequence Data | 17 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Transfection | 4 | 0.0 |
Adolescent | 3 | 0.0 |
Child | 2 | 0.0 |
Connexins/*genetics | 3 | 1.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
*Point Mutation | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Gene Duplication | 3 | 1.0 |
Genetic Screening | 2 | 0.0 |
Genotype | 3 | 0.0 |
Hereditary Motor and Sensory Neuropathies/*genetics | 3 | 6.0 |
Italy | 2 | 0.0 |
Myelin P0 Protein/genetics | 4 | 26.0 |
Phenotype | 5 | 0.0 |
Cell Line | 9 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Immediate-Early Proteins/genetics | 3 | 6.0 |
Myelin Proteins/*genetics | 3 | 2.0 |
Demyelinating Diseases/genetics | 2 | 50.0 |
English Abstract | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Immediate-Early Proteins | 3 | 1.0 |
Mice | 5 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Aged | 4 | 0.0 |
Biopsy | 3 | 0.0 |
Mutation, Missense/*genetics | 2 | 1.0 |
Sural Nerve/pathology | 2 | 4.0 |
Mice, Knockout | 2 | 0.0 |
*Trans-Activation (Genetics) | 4 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Nerve Fibers, Myelinated/pathology | 3 | 23.0 |
Neural Conduction | 2 | 2.0 |
Charcot-Marie-Tooth Disease/genetics | 4 | 16.0 |
Charcot-Marie-Tooth Disease/*genetics/pathology/physiopathology | 2 | 22.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Family Health | 3 | 0.0 |
Middle Aged | 5 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
Demyelinating Diseases/*genetics | 2 | 20.0 |
Zinc Fingers/genetics | 5 | 2.0 |
DNA Footprinting | 2 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
COS Cells | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Gene Expression Regulation/*drug effects/*physiology | 2 | 66.0 |
Calcimycin/pharmacology | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
Chromosome Banding | 2 | 0.0 |
*Chromosomes, Human, Pair 10 | 2 | 1.0 |
DNA Probes | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Gene Expression/drug effects | 2 | 0.0 |
HLA-DR Antigens/genetics | 2 | 0.0 |
Transforming Growth Factor beta/genetics | 2 | 2.0 |
Platelet-Derived Growth Factor/*genetics | 2 | 6.0 |
Karyotyping | 2 | 0.0 |
DNA/analysis/genetics | 2 | 1.0 |
Gene Expression Regulation | 2 | 0.0 |
Proto-Oncogene Proteins c-fos | 2 | 3.0 |
Sex Factors | 2 | 0.0 |
Mutation | 2 | 0.0 |
